NIELSEN KIRK G. purchased 5.2% of their position (165K shares) of SPYGLASS PHARMA, INC. on the open market
Open‑market purchase worth $2.64M — a moderate purchase. The strongest form of insider conviction signal.
Common Stock
Shares
+1.69M
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+548.07K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+548.07K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+359.25K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+165K
Price / share
$16.00
Trade value
$2.64M
% of position
Net shares
+3.31M
Net value
$2.64M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 2/9/2026 | C · Conversion | +1.69M | — | — | New position | 0.00 | 1.69M |
| Common Stock Indirect | 2/9/2026 | C · Conversion | +548.07K | — | — | 32.4% | 1.69M | 2.24M |
| Common Stock Indirect | 2/9/2026 | C · Conversion | +548.07K | — | — | 24.5% | 2.24M | 2.79M |
| Common Stock Indirect | 2/9/2026 | C · Conversion | +359.25K | — | — | 12.9% | 2.79M | 3.15M |
| Common Stock Indirect | 2/9/2026 | P · Purchase | +165K | $16.00 | $2.64M | 5.2% | 3.15M | 3.31M |
| Total | +3.31M | $2.64M | ||||||
Series B Preferred Stock
Common Stock
1.69M shares
Shares
−9.69M
Strike price
Held after
0.00
Exercisable
—
Series C-1 Preferred Stock
Common Stock
548.07K shares
Shares
−3.14M
Strike price
Held after
0.00
Exercisable
—
Series C-2 Preferred Stock
Common Stock
548.07K shares
Shares
−3.14M
Strike price
Held after
0.00
Exercisable
—
Series D Preferred Stock
Common Stock
359.25K shares
Shares
−2.06M
Strike price
Held after
0.00
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series B Preferred Stock Indirect | Common Stock1.69M shares | 2/9/2026 | C · Conversion | −9.69M | — | 0.00 | |
| Series C-1 Preferred Stock Indirect | Common Stock548.07K shares | 2/9/2026 | C · Conversion | −3.14M | — | 0.00 | |
| Series C-2 Preferred Stock Indirect | Common Stock548.07K shares | 2/9/2026 | C · Conversion | −3.14M | — | 0.00 | |
| Series D Preferred Stock Indirect | Common Stock359.25K shares | 2/9/2026 | C · Conversion | −2.06M | — | 0.00 |